Exact Mass: 585.2937776
Exact Mass Matches: 585.2937776
Found 369 metabolites which its exact mass value is equals to given mass value 585.2937776
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Amikacin
Amikacin is a semi-synthetic aminoglycoside antibiotic derived from kanamycin A. Similar to other aminoglycosides, amikacin disrupts bacterial protein synthesis by binding to the 30S ribosome of susceptible organisms. Binding interferes with mRNA binding and tRNA acceptor sites leading to the production of non-functional or toxic peptides. Other mechanisms not fully understood may confer the bactericidal effects of amikacin. Amikacin is also nephrotoxic and ototoxic. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID A239
Bluensomycin
C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Tigecycline
Tigecycline is a glycylcycline antibiotic developed and marketed by Wyeth under the brand name Tygacil. It was given a U.S. Food and Drug Administration (FDA) fast-track approval and was approved on June 17, 2005. It was developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Same as: D01079
17-AAG
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic
17-AAG
5-Hexadecanoylaminofluorescein
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
Liposomal Amikacin
Mobocertinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Tyr Phe Glu Lys
Glu Phe Tyr Lys
Amikacin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials An amino cyclitol glycoside that is kanamycin A acylated at the N-1 position by a 4-amino-2-hydroxybutyryl group. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Ala Phe Trp Tyr
Ala Phe Tyr Trp
Ala Trp Phe Tyr
Ala Trp Tyr Phe
Ala Tyr Phe Trp
Ala Tyr Trp Phe
Glu Phe Lys Tyr
Glu Lys Phe Tyr
Glu Lys Tyr Phe
Glu Tyr Phe Lys
Glu Tyr Lys Phe
Phe Ala Trp Tyr
Phe Ala Tyr Trp
Phe Glu Lys Tyr
Phe Glu Tyr Lys
Phe Phe Ser Trp
Phe Phe Trp Ser
Phe His Pro Trp
Phe His Trp Pro
Phe Lys Glu Tyr
Phe Lys Tyr Glu
Phe Pro His Trp
Phe Pro Trp His
Phe Arg Thr Tyr
Phe Arg Tyr Thr
Phe Ser Phe Trp
Phe Ser Trp Phe
Phe Thr Arg Tyr
Phe Thr Tyr Arg
Phe Trp Ala Tyr
Phe Trp Phe Ser
Phe Trp His Pro
Phe Trp Pro His
Phe Trp Ser Phe
Phe Trp Tyr Ala
Phe Tyr Ala Trp
Phe Tyr Glu Lys
Phe Tyr Lys Glu
Phe Tyr Arg Thr
Phe Tyr Thr Arg
Phe Tyr Trp Ala
His Phe Pro Trp
His Phe Trp Pro
His His His Arg
His His Arg His
His Ile Met Trp
His Ile Trp Met
His Leu Met Trp
His Leu Trp Met
His Met Ile Trp
His Met Leu Trp
His Met Trp Ile
His Met Trp Leu
His Pro Phe Trp
His Pro Trp Phe
His Arg His His
His Trp Phe Pro
His Trp Ile Met
His Trp Leu Met
His Trp Met Ile
His Trp Met Leu
His Trp Pro Phe
Ile His Met Trp
Ile His Trp Met
Ile Lys Tyr Tyr
C30H43N5O7 (585.3162328000001)
Ile Met His Trp
Ile Met Trp His
Ile Gln Tyr Tyr
Ile Trp His Met
Ile Trp Met His
Ile Tyr Lys Tyr
C30H43N5O7 (585.3162328000001)
Ile Tyr Gln Tyr
Ile Tyr Tyr Lys
C30H43N5O7 (585.3162328000001)
Ile Tyr Tyr Gln
Lys Glu Phe Tyr
Lys Glu Tyr Phe
Lys Phe Glu Tyr
Lys Phe Tyr Glu
Lys Ile Tyr Tyr
C30H43N5O7 (585.3162328000001)
Lys Leu Tyr Tyr
C30H43N5O7 (585.3162328000001)
Lys Pro Arg Trp
Lys Pro Trp Arg
Lys Arg Pro Trp
Lys Arg Trp Pro
Lys Trp Pro Arg
Lys Trp Arg Pro
Lys Tyr Glu Phe
Lys Tyr Phe Glu
Lys Tyr Ile Tyr
C30H43N5O7 (585.3162328000001)
Lys Tyr Leu Tyr
C30H43N5O7 (585.3162328000001)
Lys Tyr Tyr Ile
C30H43N5O7 (585.3162328000001)
Lys Tyr Tyr Leu
C30H43N5O7 (585.3162328000001)
Leu His Met Trp
Leu His Trp Met
Leu Lys Tyr Tyr
C30H43N5O7 (585.3162328000001)
Leu Met His Trp
Leu Met Trp His
Leu Gln Tyr Tyr
Leu Trp His Met
Leu Trp Met His
Leu Tyr Lys Tyr
C30H43N5O7 (585.3162328000001)
Leu Tyr Gln Tyr
Leu Tyr Tyr Lys
C30H43N5O7 (585.3162328000001)
Leu Tyr Tyr Gln
Met His Ile Trp
Met His Leu Trp
Met His Trp Ile
Met His Trp Leu
Met Ile His Trp
Met Ile Trp His
Met Leu His Trp
Met Leu Trp His
Met Trp His Ile
Met Trp His Leu
Met Trp Ile His
Met Trp Leu His
Pro Phe His Trp
Pro Phe Trp His
Pro His Phe Trp
Pro His Trp Phe
Pro Lys Arg Trp
Pro Lys Trp Arg
Pro Gln Arg Trp
Pro Gln Trp Arg
Pro Arg Lys Trp
Pro Arg Gln Trp
Pro Arg Trp Lys
Pro Arg Trp Gln
Pro Trp Phe His
Pro Trp His Phe
Pro Trp Lys Arg
Pro Trp Gln Arg
Pro Trp Arg Lys
Pro Trp Arg Gln
Gln Ile Tyr Tyr
Gln Leu Tyr Tyr
Gln Pro Arg Trp
Gln Pro Trp Arg
Gln Arg Pro Trp
Gln Arg Trp Pro
Gln Trp Pro Arg
Gln Trp Arg Pro
Gln Tyr Ile Tyr
Gln Tyr Leu Tyr
Gln Tyr Tyr Ile
Gln Tyr Tyr Leu
Arg Phe Thr Tyr
Arg Phe Tyr Thr
Arg His His His
Arg Lys Pro Trp
Arg Lys Trp Pro
Arg Pro Lys Trp
Arg Pro Gln Trp
Arg Pro Trp Lys
Arg Pro Trp Gln
Arg Gln Pro Trp
Arg Gln Trp Pro
Arg Thr Phe Tyr
Arg Thr Tyr Phe
Arg Trp Lys Pro
Arg Trp Pro Lys
Arg Trp Pro Gln
Arg Trp Gln Pro
Arg Tyr Phe Thr
Arg Tyr Thr Phe
Ser Phe Phe Trp
Ser Phe Trp Phe
Ser Trp Phe Phe
Thr Phe Arg Tyr
Thr Phe Tyr Arg
Thr Arg Phe Tyr
Thr Arg Tyr Phe
Thr Tyr Phe Arg
Thr Tyr Arg Phe
Trp Ala Phe Tyr
Trp Ala Tyr Phe
Trp Phe Ala Tyr
Trp Phe Phe Ser
Trp Phe His Pro
Trp Phe Pro His
Trp Phe Ser Phe
Trp Phe Tyr Ala
Trp His Phe Pro
Trp His Ile Met
Trp His Leu Met
Trp His Met Ile
Trp His Met Leu
Trp His Pro Phe
Trp Ile His Met
Trp Ile Met His
Trp Lys Pro Arg
Trp Lys Arg Pro
Trp Leu His Met
Trp Leu Met His
Trp Met His Ile
Trp Met His Leu
Trp Met Ile His
Trp Met Leu His
Trp Pro Phe His
Trp Pro His Phe
Trp Pro Lys Arg
Trp Pro Gln Arg
Trp Pro Arg Lys
Trp Pro Arg Gln
Trp Gln Pro Arg
Trp Gln Arg Pro
Trp Arg Lys Pro
Trp Arg Pro Lys
Trp Arg Pro Gln
Trp Arg Gln Pro
Trp Ser Phe Phe
Trp Tyr Ala Phe
Trp Tyr Phe Ala
Tyr Ala Phe Trp
Tyr Ala Trp Phe
Tyr Glu Phe Lys
Tyr Glu Lys Phe
Tyr Phe Ala Trp
Tyr Phe Lys Glu
Tyr Phe Arg Thr
Tyr Phe Thr Arg
Tyr Phe Trp Ala
Tyr Ile Lys Tyr
C30H43N5O7 (585.3162328000001)
Tyr Ile Gln Tyr
Tyr Ile Tyr Lys
C30H43N5O7 (585.3162328000001)
Tyr Ile Tyr Gln
Tyr Lys Glu Phe
Tyr Lys Phe Glu
Tyr Lys Ile Tyr
C30H43N5O7 (585.3162328000001)
Tyr Lys Leu Tyr
C30H43N5O7 (585.3162328000001)
Tyr Lys Tyr Ile
C30H43N5O7 (585.3162328000001)
Tyr Lys Tyr Leu
C30H43N5O7 (585.3162328000001)
Tyr Leu Lys Tyr
C30H43N5O7 (585.3162328000001)
Tyr Leu Gln Tyr
Tyr Leu Tyr Lys
C30H43N5O7 (585.3162328000001)
Tyr Leu Tyr Gln
Tyr Gln Ile Tyr
Tyr Gln Leu Tyr
Tyr Gln Tyr Ile
Tyr Gln Tyr Leu
Tyr Arg Phe Thr
Tyr Arg Thr Phe
Tyr Thr Phe Arg
Tyr Thr Arg Phe
Tyr Trp Ala Phe
Tyr Trp Phe Ala
Tyr Tyr Ile Lys
C30H43N5O7 (585.3162328000001)
Tyr Tyr Ile Gln
Tyr Tyr Lys Ile
C30H43N5O7 (585.3162328000001)
Tyr Tyr Lys Leu
C30H43N5O7 (585.3162328000001)
Tyr Tyr Leu Lys
C30H43N5O7 (585.3162328000001)
Tyr Tyr Leu Gln
Tyr Tyr Gln Ile
Tyr Tyr Gln Leu
Fosinopril sodium
C30H45NNaO7P (585.2831189999999)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
5-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-carboxymethyl-benzoic acid
Tigecycline
Tetracycline in which the hydroxy group at position 5 and the methyl group at position 6 are replaced by hydrogen, and with a dimethylamino substituent and an (N-tert-butylglycyl)amino substituent at positions 7 and 9, respectively. A glycylcycline antibiotic, it has activity against a broad range of Gram-positive and Gram-negative bacteria, including tetracycline-resistant organisms. It is used for the intravenous treatment of complicated skin and skin structure infections caused by susceptible organisms. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Same as: D01079
(2R)-3-(3-chloro-4-hydroxyphenyl)-2-[[(E,3R,8S,9S,10R)-2-ethoxy-3,9-dihydroxy-4-methoxy-6,8,10-trimethyl-7-oxotetradec-5-enoyl]amino]propanoic acid
C29H44ClNO9 (585.2704444000001)
(3S)-3-[(2S)-2-(Z-Val-Leu-Amino)-3-(2-thiazolyl)-3-oxopropyl]-2-pyrrolizinone
(4S,4aS,5aR,12aS)-9-[[2-(tert-butylamino)-1-oxoethyl]amino]-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
1,2-dioctanoyl-sn-glycero-3-phospho-1D-myo-inositol(1-)
A 1-phosphatidyl-1D-myo-inositol(1-) that is the conjugate base of 1,2-dioctanoyl-sn-glycero-3-phospho-1D-myo-inositol, obtained by deprotonation of the phosphate OH group; major species at pH 7.3.
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
1-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
1-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
1-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(3-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-pyrrolidin-1-ylethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
1-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
1-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
1-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
1-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
1-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide
N-[(3R,9R,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
N-[(3S,9R,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
N-[(5S,6R,9R)-5-methoxy-8-[(3-methoxyphenyl)methyl]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(4-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[2-(1-pyrrolidinyl)ethyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
N-[(3S,9S,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
N-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4,4,4-trifluorobutanamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(4-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[2-(1-pyrrolidinyl)ethyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(3-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[2-(1-pyrrolidinyl)ethyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
2-[(2S,4aR,12aR)-8-[(3-methoxyphenyl)sulfonylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(cyclohexylmethyl)acetamide
3-[[3-acetyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
2-amino-3-[[3-butanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
[3-acetyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
[3-butanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2R,3S,4R,5R,6S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3S,4R,5R,6S)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
phosphatidylcholine 22:4
A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 22 carbons in total with 4 double bonds.
PC(22:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(21:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PAF(20:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
3-[(4-{[hydroxy({2-[3-(c-hydroxycarbonimidoyl)-2-pentylpropanoyl]-1,2-diazinan-3-yl})methylidene]amino}-5-methyl-3-oxoheptyl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid
C27H47N5O7S (585.3196032000001)